Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $4.66 Million - $5.28 Million
55,826 Added 100.0%
111,652 $10.2 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $4.66 Million - $5.28 Million
55,826 New
55,826 $5.09 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $5.15 Million - $5.77 Million
-70,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $35.8 Million - $44.9 Million
-495,925 Reduced 87.63%
70,000 $5.37 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $32 Million - $35.2 Million
445,925 Added 371.6%
565,925 $42.5 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $5.98 Million - $6.61 Million
85,000 Added 242.86%
120,000 $9.33 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $13 Million - $15.4 Million
-189,327 Reduced 84.4%
35,000 $2.7 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $22.6 Million - $25 Million
-314,265 Reduced 58.35%
224,327 $18.4 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $39.4 Million - $44.7 Million
538,592 New
538,592 $44.7 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $71.7 Million - $83.8 Million
-1,027,100 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $71.5 Million - $81.5 Million
1,027,100 New
1,027,100 $85.4 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $7.83 Million - $9.09 Million
-120,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $6.92 Million - $8.14 Million
120,000 New
120,000 $8.51 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $46.9 Million - $55.2 Million
-923,600 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $47.1 Million - $54.7 Million
923,600 New
923,600 $50.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.